Riskpilot← Back to searchSign inGet full accessPeptiSystems AB
ABActiveOrg 5569940991Virdings Allé 32 BResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20145-9 employees
Revenue 2024
SEK 15,7M
-52% vs 2023
EBITDA margin
-73.4%
-312% vs 2023
Equity ratio
84.2%
Financial strength
Net profit 2024
SEK -13,9M
-449% vs 2023
| Revenue | SEK 15,7M | -52% |
| EBITDA | SEK -11,5M | -312% |
| Net profit | SEK -13,9M | -449% |
| Total assets | SEK 57,5M | +61% |
| Equity | SEK 48,4M | +96% |
| Employees | — | — |
Legal name
PeptiSystems AB
Org number
5569940991
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
8 december 2014
Share capital
SEK 115 370
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Granath, Karin Firman tecknas två i förening av ledamöterna
Company purpose
Bolaget ska, direkt eller indirekt, bedriva forskning, utveckling, tillverkning och försäljning av instrument, förbrukningsartiklar och processer inom life-science området samt idka annan därmed förenlig verksamhet.
Address
Virdings Allé 32 B
Email
karin.granath@peptisystems.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 11 | 0 | 0 | 154 | 9 833 | 32 971 | 15 677 |
| Staff expenses | — | — | — | — | — | — | — | −8 362 | −14 634 |
| EBITDA | 34 | −288 | −448 | −4 530 | −6 183 | −2 633 | 3 804 | 5 418 | −11 509 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −744 | −1 048 | −2 287 |
| EBIT | 34 | −288 | −448 | −4 530 | −6 183 | −2 633 | 3 060 | 4 370 | −13 796 |
| Net financials | — | −3 | −46 | −95 | −214 | −296 | −371 | −393 | −92 |
| Profit before tax | 34 | −291 | −493 | −4 625 | −6 397 | −2 930 | 2 689 | 3 977 | −13 888 |
| Tax | −9 | −0 | −0 | −0 | −0 | −0 | −0 | — | — |
| Net profit | 25 | −291 | −493 | −4 625 | −6 397 | −2 930 | 2 689 | 3 977 | −13 888 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 75 | 97 | 1 014 | 2 723 | 1 815 | 13 383 | 23 265 | 35 609 | 57 480 |
| Equity | 75 | 91 | −361 | 1 214 | −2 183 | −5 113 | −2 424 | 24 652 | 48 369 |
| Long-term debt | 0 | 0 | 1 325 | 725 | 3 275 | 6 875 | 2 806 | 1 872 | 300 |
| Short-term debt | 0 | 6 | 50 | 785 | 723 | 11 621 | 22 392 | 6 359 | 7 121 |
| Total debt | — | 6 | 1 375 | 1 510 | 3 998 | 18 496 | 25 198 | 8 231 | 7 421 |
EBITDA margin
-73.4%
This company
15.8%
Market median
-565% vs market
20162024
Equity ratio
84.2%
This company
38.2%
Market median
+120% vs market
20162024
Return on equity
-28.7%
This company
18.4%
Market median
-256% vs market
20162024
Net profit margin
-88.6%
This company
8.1%
Market median
-1194% vs market
20162024
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20162024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-02-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-02-01 – 2017-01-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2014-12-01 – 2016-01-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SM Chief Auditor | Chief Auditor | 2025 | — | — |
KL Audit | Audit | 2023 | — | — |
KG Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2025 | — | — | |
| Deputy Board Member | 2026 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PeptiSystems AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sara Maria Charlotta Wallinder | Chief Auditor | 0 companies |
| Karl Leonard Daun | Audit | 0 companies |
| Karin Granath | Chief Executive Officer | 0 companies |
| Ulf Cronje Tedebark | Board of Directors | 0 companies |
| Anders Patrik Hedlund | Board of Directors | 0 companies |
| Nicolas Henry Roelofs | Board of Directors | 0 companies |
| Sebastian Schmidt Intveen | Deputy Board Member | 0 companies |
| Mats Olof Rickard Johnson | Chairman | 0 companies |
| Mats Olof Israelsson | Board of Directors | 0 companies |
| Ole Jesper Dahlberg | Board of Directors | 0 companies |
| John Allan Asp | Board of Directors | 0 companies |
| Markus Sebastian Holmberg | Deputy Board Member | 0 companies |
| Ida Helena Christina Strigård | Board of Directors | 0 companies |
| Lars-Åke Holmberg | Board of Directors | 0 companies |
| Rannar Sillard | Chairman | 0 companies |